Evaluating the antidiabetic effects of R-verapamil in type 1 and type 2 diabetes mellitus mouse models.

Saved in:
Bibliographic Details
Title: Evaluating the antidiabetic effects of R-verapamil in type 1 and type 2 diabetes mellitus mouse models.
Authors: Chen YS; Center Laboratories Inc., Taipei, Taiwan, R.O.C., Weng SJ; Lumosa Therapeutics Co., Ltd., Taipei, Taiwan, R.O.C., Chang SH; Lumosa Therapeutics Co., Ltd., Taipei, Taiwan, R.O.C., Li RY; Center Laboratories Inc., Taipei, Taiwan, R.O.C., Shane GT; Center Laboratories Inc., Taipei, Taiwan, R.O.C., Hsu JP; Center Laboratories Inc., Taipei, Taiwan, R.O.C., Yeh SW; Lumosa Therapeutics Co., Ltd., Taipei, Taiwan, R.O.C., Chang AC; Center Laboratories Inc., Taipei, Taiwan, R.O.C., Lee MJ; Center Laboratories Inc., Taipei, Taiwan, R.O.C.
Source: PloS one [PLoS One] 2021 Aug 06; Vol. 16 (8), pp. e0255405. Date of Electronic Publication: 2021 Aug 06 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One
Database: MEDLINE Ultimate
Description
ISSN:1932-6203
DOI:10.1371/journal.pone.0255405